Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Genenta Science SpA ADR

GNTA
Current price
5 USD +0.09 USD (+1.83%)
Last closed 4.81 USD
ISIN US36870W1009
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 89 620 512 USD
Yield for 12 month -3.85 %
1Y
3Y
5Y
10Y
15Y
GNTA
21.11.2021 - 28.11.2021

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy. Address: Via Olgettina No. 58, Milan, MI, Italy, 20132

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

23 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-44 318 USD

Last Year

-6 426 USD

Current Quarter

-22 257 USD

Last Quarter

Key Figures GNTA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -9 407 693 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -25.83 %
PEG Ratio
Return On Equity TTM -42.89 %
Wall Street Target Price 23 USD
Revenue TTM
Book Value 0.92 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.53 USD
Diluted Eps TTM -0.53 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GNTA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GNTA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GNTA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -11.4756
Price Book MRQ 4.9659

Financials GNTA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators GNTA

For 52 weeks

2.2 USD 7.28 USD
50 Day MA 4.69 USD
Shares Short Prior Month 4 548
200 Day MA 3.95 USD
Short Ratio 0.56
Shares Short 11 610
Short Percent 0.1 %